Company profile

M.A. Med Alliance SA

MedAlliance is a privately-owned medical technology company. It is headquartered in Nyon, Switzerland, with offices in  Germany, Singapore, UK and USA. MedAlliance has been dedicated to developing innovative drug-eluting balloons (DEBs) for patients suffering from life-threatening coronary and peripheral arterial disease. Using breakthrough proprietary technology, MedAlliance has found a unique solution to the challenge of controlled and sustained sirolimus release with SELUTION SLR™.

More news about M.A. Med Alliance SA

20.10.2022 13:20

MedAlliance’s acquisition by Cordis to deliver up to $1.1 billion

Please login or
register to use the
awards follow feature
11.08.2022 14:59

MedAlliance SELUTION SLR receives second FDA IDE approval

Please login or
register to use the
awards follow feature
25.03.2022 12:00

Tech Tour and Viva Tech nominate Switzerland’s growth startups

Please login or
register to use the
awards follow feature
13.08.2021 10:54

MedAlliance to kick-off clinical trials of its drug-eluting balloon

Please login or
register to use the
awards follow feature
M.A. Med Alliance SA

Founded
2008

Kanton
Vaud


LinkedIn

Twitter
@MedallianceSA

Homepage

rss